Skip to main content

Table 3 Comparison of the average period until normalization of hepatic enzymes in the severe DIH and its HREZ regimen group

From: Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

 

Patients who have stopped anti-TB drugs and with hepatoprotective drugs

Patients who have stopped anti-TB drugs and without hepatoprotective drugs

P value

severe DIH group

21 ± 10 days

(N = 17)

21 ± 11 days

(N = 6)

0.97

HREZ group

21 ± 8 days

(N = 11)

24 ± 10 days

(N = 5)

0.64

  1. Data are expressed as means ± standard error
  2. Abbreviations: H isoniazid, R rifampicin, E ethambutol, Z pyrazinamide